Table 2.
Clinical characteristics
| Nipple eczema with AD (Group I) (n = 39) | Nipple eczema without AD (Group II) (n = 61) | p-Value | |
|---|---|---|---|
| Mean age (years) | 27.4 | 28.6 | 0.07 |
| Parity | P1 = 35.9% | P1 = 39.4% | 0.87 |
| P2 = 53.8% | P2 = 50.8% | ||
| >P2 = 10.3% | >P2 = 9.8% | ||
| Trimester of pregnancy | T1 – 28.5% | T1 – 32.1% | 0.21 |
| T2 – 49.4% | T2 – 37.7% | ||
| T3 – 22.1% | T3 – 30.2% | ||
| Duration of eczema (in weeks) | 24.5 | 22.7 | 0.19 |
| Laterality (uni/bilateral) | Bi = 79.4% | Bi = 63.9% | 0.09 |
| Total leukocyte count (per μL) | 8387.1 | 6942.8 | <0.01 |
| Differential leukocyte count (% of eosinophils) | 6.6 ± 5.1 | 2.1 ± 1.7 | <0.01 |
| Absolute eosinophil count/μL | 392.5 ± 202.8 | 107.3 ± 81.6 | <0.01 |
| Serum IgE levels (IU/mL) | 310.5 | 292.7 | 0.17 |